An Open Letter and Call to Action for MAPS Canada

The following is an open letter by two former co-leads of the MAPS Canada Diversity Committee. It was written in response to a variety of racist and prejudicial behaviours they experienced from MAPS Canada leadership and the organization at large during their eight-month tenure as unpaid volunteers, including obstruction—by leadership—of their efforts to address long-entrenched discriminatory practices in the psychedelic research domain and to implement initiatives to combat race-based health disparities.


MindMed’s CEO Jamon “JR” Rahn Wants Nothing To Do With Those Psychedelic Decrim People

"I want nothing to do with those kinds of folks who want to decriminalize psychedelics,” Rahn told Forbes."


Is Ibogaine the Cure for Opioid Addiction? It’s Not That Simple. | Part 11

The Ibogaine Conversation Conclusion | The goal of this conversation was to provide a platform for a diverse range of perspectives on a single topic. Not everyone agrees, and that’s the point.


Rick Doblin Is No Longer MAPS’ Executive Director. We Didn’t Notice — Did You?

The Multidisciplinary Association for Psychedelic Studies (MAPS) quietly replaced founder Rick Doblin as Executive Director with Kris Lotlikar.


Dorion Sagan on Carl Sagan, Lynn Margulis, and his new book, Cracking the Aging Code

In this interview I talk with Dorion Sagan about whether his father Carl Sagan used LSD, his mother Lynn Margulis’s paradigm-changing theory of symbiogenesis, her thoughts on psychedelics, and his new book Cracking the Aging Code: The New Science of Growing Old-And What It Means for Staying Young.


Meet the hypnotist who can get you high – without any drugs.

I hypnotized some of the attendees and put them on cocaine, pot, beer, and even ecstasy. I interviewed them afterwards and asked them if it felt real. And each of them said yes. Quite real. Then my head exploded.


Hamilton Morris Hired by Psilocybin Startup COMPASS Pathways, Ends “Hamilton’s Pharmacopeia” On Vice

Hamilton Morris, the creator of Vice’s “Hamilton’s Pharmacopeia,” will cease working with Vice on the show following the third season. He has joined psychedelic pharmaceutical corporation COMPASS Pathways as a chemistry consultant.


Why are so many extractive industry executives speculating on psychedelics?

Extractive industry is highly speculative by nature and firms are risk tolerant—they either “strike gold” or they don’t. When their gambles fail, psychedelic startups can take over their corporate shells to quickly go public with minimal regulatory scrutiny.


Christopher Valore (AKA The Architect) talks “Conductor,” His Virtual-Reality, Psychedelic-Visual Sandbox Platform

Christopher Valore discusses his love of virtual reality; the early days of his company, Club Transcendia; and development of his first official release, “Conductor.”


A Channel for Magic: Ralph Hood’s Mysticism Scale and the Occult Roots of the Johns Hopkins Psychedelic Research Program

Psychologist Ralph Hood’s study of serpent handling and mysticism helped legitimize the study of psychedelics. So why doesn't he want them approved for medical use?